949 related articles for article (PubMed ID: 19378860)
1. [Bleeding complications of anticoagulant therapy].
Gumulec J; Kessler P; Procházka V; Brejcha M; Penka M; Zänger M; Machytka E; Klement P
Vnitr Lek; 2009 Mar; 55(3):277-89. PubMed ID: 19378860
[TBL] [Abstract][Full Text] [Related]
2. Reversing anticoagulants both old and new.
Warkentin TE; Crowther MA
Can J Anaesth; 2002; 49(6):S11-25. PubMed ID: 12557411
[TBL] [Abstract][Full Text] [Related]
3. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
4. [Hemorrhagic complications during warfarin treatment].
Gumulec J; Kessler P; Penka M; Klodová D; Králová S; Brejcha M; Wróbel M; Sumná E; Blatný J; Klaricová K; Riedlová P; Lasota Z
Vnitr Lek; 2006 Mar; 52 Suppl 1():79-91. PubMed ID: 16637455
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for bleeding in patients taking coumarins.
Beyth RJ; Milligan PE; Gage BF
Curr Hematol Rep; 2002 Sep; 1(1):41-9. PubMed ID: 12901124
[TBL] [Abstract][Full Text] [Related]
6. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
7. Reversal of Anticoagulation and Management of Bleeding in Patients on Anticoagulants.
Dhakal P; Rayamajhi S; Verma V; Gundabolu K; Bhatt VR
Clin Appl Thromb Hemost; 2017 Jul; 23(5):410-415. PubMed ID: 27789605
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulants and their reversal.
Schulman S; Bijsterveld NR
Transfus Med Rev; 2007 Jan; 21(1):37-48. PubMed ID: 17174219
[TBL] [Abstract][Full Text] [Related]
9. Warfarin-induced bleeding complications - clinical presentation and therapeutic options.
Wiedermann CJ; Stockner I
Thromb Res; 2008; 122 Suppl 2():S13-8. PubMed ID: 18549907
[TBL] [Abstract][Full Text] [Related]
10. Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management.
Levi MM; Eerenberg E; Löwenberg E; Kamphuisen PW
Neth J Med; 2010 Feb; 68(2):68-76. PubMed ID: 20167958
[TBL] [Abstract][Full Text] [Related]
11. Current challenges of anticoagulant treatment.
Ginghină C; Giuşcă S; Serban M; Popescu BA; Jurcuţ R; Uscăţescu V
Rom J Intern Med; 2007; 45(3):221-7. PubMed ID: 18333353
[TBL] [Abstract][Full Text] [Related]
12. Developing a management plan for oral anticoagulant reversal.
Dager WE
Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S21-31. PubMed ID: 23640529
[TBL] [Abstract][Full Text] [Related]
13. Approaches to diagnosing and managing anticoagulant-related bleeding.
Goy J; Crowther M
Semin Thromb Hemost; 2012 Oct; 38(7):702-10. PubMed ID: 23034830
[TBL] [Abstract][Full Text] [Related]
14. Reversal of antithrombotic agents.
Bauer KA
Am J Hematol; 2012 May; 87 Suppl 1():S119-26. PubMed ID: 22460529
[TBL] [Abstract][Full Text] [Related]
15. [Present and future of oral anticoagulants].
Meschengieser SS; Casais P; Sánchez Luceros A; Lazzari MA
Medicina (B Aires); 2000; 60(1):139-42. PubMed ID: 10835711
[TBL] [Abstract][Full Text] [Related]
16. Analysis and occurrence of adverse events with oral anticoagulant therapy.
Schenk JF; Mörsdorf S; Pindur G; Munter KH; Thrun F; Tiaden JD; Wenzel E
Semin Thromb Hemost; 1999; 25(1):65-71. PubMed ID: 10327223
[TBL] [Abstract][Full Text] [Related]
17. Thrombomodulin as a marker for bleeding complications during warfarin treatment.
Lind M; Boman K; Johansson L; Nilsson TK; Ohlin AK; Birgander LS; Jansson JH
Arch Intern Med; 2009 Jul; 169(13):1210-5. PubMed ID: 19597070
[TBL] [Abstract][Full Text] [Related]
18. Discrepancies in identification of major bleeding events in patients taking warfarin.
Seto AC; Kenyon K; Wittkowsky AK
Pharmacotherapy; 2008 Sep; 28(9):1098-103. PubMed ID: 18752380
[TBL] [Abstract][Full Text] [Related]
19. French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding).
Pernod G; Godiér A; Gozalo C; Tremey B; Sié P;
Thromb Res; 2010 Sep; 126(3):e167-74. PubMed ID: 20630568
[TBL] [Abstract][Full Text] [Related]
20. Current anticoagulant safety.
Denas G; Pengo V
Expert Opin Drug Saf; 2012 May; 11(3):401-13. PubMed ID: 22390628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
